{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:10:08Z","timestamp":1749809408472,"version":"3.41.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1136\/ard-2023-225217","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T18:20:18Z","timestamp":1709144418000},"page":"1403-1405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Referral of patients with suspected polymyalgia rheumatica: how complete is our view of \u2018planet PMR?\u2018"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-6458","authenticated-orcid":false,"given":"Dario","family":"Camellino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225217_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12891-016-1127-3","article-title":"The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population","volume":"17","author":"Yates","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1136\/ard-2023-225217_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ard.60.11.1021","article-title":"Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study","volume":"60","author":"Caporali","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"Provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/03009742.2023.2215044","article-title":"Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland","volume":"52","author":"Paltta","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2023-225217_bib6","doi-asserted-by":"crossref","first-page":"rkz033","DOI":"10.1093\/rap\/rkz033","article-title":"Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care","volume":"3","author":"Fors","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"10.1136\/ard-2023-225217_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3399\/bjgp18X699557","article-title":"Challenges of diagnosing and managing polymyalgia rheumatica","volume":"68","author":"Helliwell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1136\/ard-2023-225217_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.40.1.1","article-title":"Prognosis and management of polymyalgia rheumatica","volume":"40","author":"Jones","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","article-title":"Patient-reported outcomes in polymyalgia rheumatica","volume":"39","author":"Matteson","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225217_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-225217_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4081\/reumatismo.2018.1036","article-title":"The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica","volume":"70","author":"Sobrero","year":"2018","journal-title":"Reumatismo"},{"key":"10.1136\/ard-2023-225217_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/art.21160","article-title":"Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease","volume":"53","author":"Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00296-014-3034-y","article-title":"The process from symptom onset to rheumatology clinic in polymyalgia rheumatica","volume":"34","author":"Dalk\u0131l\u0131\u00e7","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard-2023-225217_bib15","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225217_bib16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"Recommendations for the management of polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/ard-2023-225134","article-title":"Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group","volume":"83","author":"Keller","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib18","doi-asserted-by":"crossref","first-page":"152260","DOI":"10.1016\/j.semarthrit.2023.152260","article-title":"Early referral of patients with suspected polymyalgia rheumatica - a systematic review","volume":"63","author":"Nielsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis","volume":"180","author":"van der Geest","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1136\/ard-2023-225217_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3899\/jrheum.160232","article-title":"Are the new ACR\/EULAR criteria the ultimate answer for polymyalgia rheumatica classification","volume":"43","author":"Camellino","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225217_bib21","doi-asserted-by":"crossref","first-page":"152069","DOI":"10.1016\/j.semarthrit.2022.152069","article-title":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - a systematic review and meta-analysis","volume":"56","author":"Nielsen","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225217_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/ard-2023-225192","article-title":"Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndrome","volume":"83","author":"Bond","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib23","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1136\/annrheumdis-2013-203465","article-title":"Is cancer associated with Polymyalgia Rheumatica? A cohort study in the general practice research database","volume":"73","author":"Muller","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225217_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(22)00532-3","article-title":"Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"399","author":"GBD 2019 Human Resources for Health Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ard-2023-225217_bib25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keaa646","article-title":"New insights into the role of imaging in polymyalgia rheumatica","volume":"60","author":"Camellino","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225217_bib26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/cts.13649","article-title":"Prevalence and prescribing patterns of oral corticosteroids in the United States, Taiwan, and Denmark, 2009-2018","volume":"16","author":"Wallace","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1136\/ard-2023-225217_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/ard-2023-225217_bib28","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225217_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen.14114","article-title":"High prescription rate of oral glucocorticoids in children and adults: a retrospective cohort study from Western Sweden","volume":"92","author":"Einarsdottir","year":"2020","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:38:05Z","timestamp":1749807485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724665325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0003496724665325"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225217","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Referral of patients with suspected polymyalgia rheumatica: how complete is our view of \u2018planet PMR?\u2018","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225134","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}